Kalypsys kalypsys.com


Public lists: Pharma Startups (4740)

Kalypsys is a drug discovery company using a cellular ultra high-throughput system to carry out massive drug screening in cellular models of human disease and toxicology.

Kalypsys is a drug discovery company using a cellular ultra high-throughput system to carry out massive drug screening in cellular models of human disease and toxicology.

Company (Alive / Active)

Phone: 858-754-3300

Fax: 858-754-3301

10420 Wateridge Circle

San Diego, 92121
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Kalypsys $172M Nov 25, 2006
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Kalypsys Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
5AM VenturesVenture CapitalMenlo Park, California, United StatesSeries B, Series A
Aravis VenturesVenture CapitalSwitzerlandOther Investors
Affentranger AssociatesVenture CapitalSwitzerlandOther Investors
BioVenture FundVenture CapitalCambridge, Massachusetts, United StatesOther Investors
EDBIAsset/Investment ManagementSingaporeSeries A, Other Investors
See all 17 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Bicyclic heteroaryl inhibitors of pde4 Jun 28, 2012 Jul 14, 2015 Patent
Heterocyclic inhibitors of histamine receptors for the treatment of disease Sep 07, 2012 Oct 14, 2014 Patent
Bicyclic heteroaryl inhibitors of pde4 Jul 06, 2007 Sep 04, 2012 Patent
Heteroarylalkoxy-substituted quinolone inhibitors of pde4 Aug 19, 2009 Mar 20, 2012 Patent
Carbazole inhibitors of histamine receptors for the treatment of disease Jun 11, 2009 Dec 20, 2011 Patent
See all 12 patents